COVIR

COVIR

Created using Figma
Octopusrobots, a company listed on the stock exchange on Access, filed a patent on February 7, 2017 PCT / FR2017 / 050277 (valid for 20 years i.e. 2037) and is developing a technology for air disinfection (spray) of spaces and surfaces potentially contaminated by viruses e.g. Covid-19, or bacteria.
The global containment measures do not allow to classically negotiate "face to face" with Asian, Russian, US customers etc… and the financing being very urgent and important to industrialize quickly it was decided to use digital methods to strengthen the effectiveness of financing implementations and finding resources and solutions outside of conventional financial systems (banks, funds, etc.)
In partnership with COVIR.IO operational pre-financing vehicle; Octopusrobots launches the prefinancing of its global portfolio of
potential licenses by TOKENIZING ITS LICENSING RIGHTS ON THE TEZOS BLOCKCHAIN. The solution is up and running since 2015. Octopus robots is already 20 years old.
Los datos no están disponibles
10 mar 2020
1 ago 2020
100% terminado
Fondos recaudados - sin datos
Gol 4 000 000.00 USD
Gorra 4 000 000.00 USD
past
  • 1 CVR
    =
    0.2 USD
Detalles del token
Corazón
CVR
Suministro total
400000000
Monedas aceptadas
XTZ, ETH, BTC, USD, TRX
Contribución mínima
50
USD
Detalles de la compañía
Nombre de la empresa registrada
Pagest Environnement
País registrado
Switzerland
Detalles adicionales
MVP / Prototipo
Plataforma
Tezos
Categorías
Plataforma

Acerca de COVIR

Covir is a platform that is designed to fund biosafety projects and licenses using blockchain technology. Biosafety licenses funded by Covir are for Octopus robots products; Octopus robots design biosafety equipment that decontaminates large buildings such as shopping malls, airport terminals, and food processing plants. Without a doubt, Covir project is the best blockchain project to invest in because biosafety projects are currently underrepresented in the blockchain world, despite there being a lot of opportunities in the biosafety industry. The current ravaging COVID-19 pandemic has accelerated the need for biosafety equipment.

COVIR Roadmap

  • RoadMap for 2020 v1.2

  • https://covir.fr/wp-content/uploads/2020/document/CovirRoadMap2020-v1.2.pdf

COVIR Equipo

Verificado 0%

Atención. Existe el riesgo de que los miembros no verificados no sean realmente miembros del equipo

William Baude
Deputy Director - Data R&D - CTO Expert Crypto
inconfirmado
Zied Chaabane
Arabic Manager & Project Manager
inconfirmado

COVIR Últimas noticias

  • Debido a que puede haber diferencias de tiempo en las actualizaciones de información, la información precisa sobre cada proyecto ICO debe verificarse a través de su sitio web oficial u otros canales de comunicación.
  • Esta información no es una sugerencia o consejo para invertir en fondos de la OIC. Por favor, investigue a fondo la información relevante y decida la participación de la OIC.
  • Si cree que hay problemas o correcciones a corregir en este contenido, o si desea enviar su propio proyecto ICO para que aparezca en la lista, por favor envíenos un correo electrónico.
Lea la exención de responsabilidad y la advertencia de riesgo. Mostrar descargo de responsabilidad y advertencia de riesgo.